Pentraxin 3 in acute respiratory distress syndrome: An early marker of severity
Pentraxin 3 in acute respiratory distress syndrome: An early marker of severity
复制标题
DOI:
10.1097/ccm.0b013e3181809aaf
复制
发表时间:
2008-08-01
影响因子:
8.8
通讯作者:
Pesenti, Antonio
中科院分区:
文献类型:
--
作者:
Mauri, Tommaso;Coppadoro, Andrea;Pesenti, Antonio
Objective: Pentraxin 3 is a fluid phase receptor involved in innate immunity. It belongs to the Pentraxins family, as C-reactive protein does. Pentraxin 3 is produced by a variety of tissue cells, whereas only the liver produces C-reactive protein. Pentraxin 3 plays a unique role in the regulation of inflammation. Acute lung injury and acute respiratory distress syndrome are characterized by an important inflammatory reaction. We investigated the role of pentraxin 3 as a marker of severity and outcome predictor of acute lung injury and acute respiratory distress syndrome.Design: We measured circulating pentraxin 3 and C-reactive protein levels within 24 hrs from intubation (day 1), after 24 hrs from the first sample, then every 3 days for the first month and then once a week, until discharge from the intensive care unit. Pentraxin 3 was also measured in bronchoalveolar lavages, performed when clinically indicated.Setting: One university medical center general intensive care unit.Patients: The study included 21 patients affected by acute lung injury and acute respiratory distress syndrome (1994 Consensus Conference criteria).Interventions: None.Measurements and Main Results: Pentraxin 3 plasma levels were high with a peak on the first day (median 71.05 ng/mL, interquartile range 52.37-117.38 ng/mL, normal values